Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Sauer

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
ESC Heart Failure|December 24, 2024
Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE-HF and PRESERVED-HFAndrew P Ambrosy, Andrew J Sauer, Shachi Patel, et al.
Pacing and Clinical Electrophysiology : PACE|January 3, 2022
Impact of ultra-conservative ICD programming in patients with LVADs: Avoiding potentially unnecessary tachy-therapiesAlexander Robinson, Valay Parikh, Mohammad-Ali Jazayeri, et al.
The American Journal of Cardiology|March 22, 2023
Impact of Biopsy Proven Liver Fibrosis on Patients Undergoing Evaluation and Treatment for Advanced Heart Failure Surgical TherapiesAmandeep Goyal, Tarun Dalia, Sagar Ranka, et al.
American Heart Journal|June 5, 2025
Rationale, design, and baseline characteristics of the virtual care to improve heart failure outcomes (VITAL-HF) trialMirza S Khan, Andrew J Sauer, Cynthia L Green, et al.
Frontiers in Cardiovascular Medicine|March 20, 2023
Impact of exercise on pulmonary artery pressure in patients with heart failure using an ambulatory pulmonary artery pressure monitorRola Khedraki, Jacob Abraham, Orvar Jonsson, et al.
JACC. Heart Failure|February 28, 2025
Left Atrial-to-Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT-FLOW Trial (Early Feasibility Study) 2-Year ResultsFrancesco Fioretti, Benjamin Hibbert, Peter M Eckman, et al.
JACC. Heart Failure|April 19, 2024
Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF TrialSenthil Selvaraj, Shachi Patel, Andrew J Sauer, et al.
Circulation. Heart Failure|October 23, 2023
Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HFGregory D Lewis, Kensey Gosch, Laura P Cohen, et al.
Journal of Cardiac Failure|March 28, 2026
Patiromer for Patients with Heart Failure at Risk of Hyperkalemia: CARE-HK in HF RegistryOmar Cantu Martinez, Stephen J Greene, Khaja M Chinnakondepalli, et al.
Circulation. Heart Failure|January 10, 2022
Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility StudyNavin K Kapur, Michael S Kiernan, Irakli Gorgoshvili, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
ESC Heart Failure|December 24, 2024
Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE-HF and PRESERVED-HFAndrew P Ambrosy, Andrew J Sauer, Shachi Patel, et al.
Pacing and Clinical Electrophysiology : PACE|January 3, 2022
Impact of ultra-conservative ICD programming in patients with LVADs: Avoiding potentially unnecessary tachy-therapiesAlexander Robinson, Valay Parikh, Mohammad-Ali Jazayeri, et al.
The American Journal of Cardiology|March 22, 2023
Impact of Biopsy Proven Liver Fibrosis on Patients Undergoing Evaluation and Treatment for Advanced Heart Failure Surgical TherapiesAmandeep Goyal, Tarun Dalia, Sagar Ranka, et al.
American Heart Journal|June 5, 2025
Rationale, design, and baseline characteristics of the virtual care to improve heart failure outcomes (VITAL-HF) trialMirza S Khan, Andrew J Sauer, Cynthia L Green, et al.
Frontiers in Cardiovascular Medicine|March 20, 2023
Impact of exercise on pulmonary artery pressure in patients with heart failure using an ambulatory pulmonary artery pressure monitorRola Khedraki, Jacob Abraham, Orvar Jonsson, et al.
JACC. Heart Failure|February 28, 2025
Left Atrial-to-Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT-FLOW Trial (Early Feasibility Study) 2-Year ResultsFrancesco Fioretti, Benjamin Hibbert, Peter M Eckman, et al.
JACC. Heart Failure|April 19, 2024
Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF TrialSenthil Selvaraj, Shachi Patel, Andrew J Sauer, et al.
Circulation. Heart Failure|October 23, 2023
Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HFGregory D Lewis, Kensey Gosch, Laura P Cohen, et al.
Journal of Cardiac Failure|March 28, 2026
Patiromer for Patients with Heart Failure at Risk of Hyperkalemia: CARE-HK in HF RegistryOmar Cantu Martinez, Stephen J Greene, Khaja M Chinnakondepalli, et al.
Circulation. Heart Failure|January 10, 2022
Intermittent Occlusion of the Superior Vena Cava to Improve Hemodynamics in Patients With Acutely Decompensated Heart Failure: The VENUS-HF Early Feasibility StudyNavin K Kapur, Michael S Kiernan, Irakli Gorgoshvili, et al.
Pageof 10